Nutraceutical: Wellmune
 
Indication: Allergy symptoms
 
Source:Experimental Biology Conference, April 2011.
 
Research: This study equally divided 48 healthy subjects (31 female, 17 male; 39 ± 13 years of age) into two groups. One group consumed a placebo while the other a 250 mg serving of Wellmune WGP daily for 4 weeks during last September/October in an area of southeast Ohio where local pollen counts were high. Allergy surveys, including the validated Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), were used to assess differences in allergy symptoms.
 
Results: Individuals consuming Wellmune WGP, a natural immune health ingredient from Biothera, noted statistically significant reductions in overall allergy symptoms and severity, as well as reductions in key nasal and eye-related allergy symptoms. There was also significant improvement on the Quality of Life Index, a scientifically validated tool for measuring how participants rate their overall sense of wellness.